Why Sell This Pharma Dividend Stock Today?

Large companies in the health care space, such as drugmaker Merck  (NYSE: MRK  ) , are typically insulated from general secular trends and tend to make good defensive plays for long-term investors. However, this rule of thumb should be taken with a grain of salt; not every pharmaceutical company is the right fit for your portfolio, and investors always need to consider the bull and bear theses of their investments. In this video, our health care analyst dives into the bear thesis for Merck.  

For nearly 100 years, Merck's cutting-edge research has led to a number of medical breakthroughs. or more detailed information, make sure you take a look at our brand new premium research report today. Our senior biotech analyst Brian Orelli, Ph.D., walks you through both the opportunities and threats facing Merck, and the report comes with a full 12 months of updates. Claim your copy now by clicking here.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2227072, ~/Articles/ArticleHandler.aspx, 9/17/2014 1:31:11 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement